Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema

American Journal of Respiratory Cell and Molecular Biology

Volumn 22, Issue 6, 2000, Pages 657-664

  Kaner, Robert J ^a,b   Ladetto, John V ^a,b   Singh, Ravi ^a,b   Fukuda, Norimasa ^a,b   Matthay, Michael A ^a,b   Crystal, Ronald G ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRIDAE; ANIMALIA; EUKARYOTA;

EID: 0034086608     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.22.6.3779     Document Type: Article

References (61)

1. 1. Goodman, B. E., K. J. Kim, and E. D. Crandall. 1987. Evidence for active sodium transport across alveolar epithelium of isolated rat lung. J. Appl. Physiol. 62:2460-2466.
2. 2. Matthay, M. A., C. C. Landolt, and N. C. Staub. 1982. Differential liquid and protein clearance from the alveoli of anesthetized sheep. J. Appl. Physiol. 53:96-104.
3. 3. Matthay, M. A., Y. Berthiaume, and N. C. Staub. 1985. Long-term clearance of liquid and protein from the lungs of unanesthetized sheep. J. Appl. Physiol. 59:928-934.
4. 4. Staub, N. C. 1974. Pulmonary edema. Physiol. Rev. 54:678-811.
5. 5. Effros, R. M., G. R. Mason, J. Hukkanen, and P. Silverman. 1989. New evidence for active sodium transport from fluid-filled rat lungs. J. Appl. Physiol. 66:906-919.
6. 6. Chander, A., and A. B. Fisher. 1990. Regulation of lung surfactant secretion. Am. J. Physiol. 258:L241-L253.
7. 7. Kim, K.-J., and E. D. Crandall. 1994. Specialized alveolar epithelial transport processes. In Fluid and Solute Transport in the Airspaces of the Lungs. R. M. Effros and K. Chang, editors. Marcel Dekker, New York. 219-248.
8. 8. Staub, N. C., H. Nagano, and M. L. Pearce. 1967. Pulmonary edema in dogs, especially the sequence of fluid accumulation in lungs J. Appl. Physiol. 22:227-240.
9. 9. Flick, M. R. 1994. Pulmonary edema and acute lung injury. In Textbook of Respiratory Medicine. J. F. Murray and J. F. Nadel, editors. W. B. Saunders Company, Philadelphia. 1725-1777.
10. 10. Guyton, A. C., and A. W. Lindsey. 1959. Effect of elevated atrial pressure and decreased plasma protein concentration of the development of pulmonary edema. Circ. Res. 7:649-657.
11. 11. Simionescu, M. 1997. Lung endothelium: structure-function correlates. In The Lung: Scientific Foundations. R. G. Crystal and J. B. West, editors. Lippincott-Raven Publishers, Philadelphia. 615-627.
12. 12. Schneeberger, E. E. 1978. Structural basis for some permeability properties of the air-blood barrier. Fed. Proc: 37:2471-2478.
13. 13. Bhattacharya, J. 1998. Physiological basis of pulmonary edema. In Pulmonary Edema. M. A. Matthay and D. H. Ingbar, editors. Marcel Dekker, New York. 1-36.
14. 14. Pietra, G. G., A. P. Fishman, P. N. Lanken, P. Sampson, and J. Hansen-Flaschen. 1982. Permeability of pulmonary endothelium to neutral and charged macromolccules. Ann. NY Acad. Sci. 401:241-247.
15. 15. Palade, G. E. 1997. Role of plasmalemmal vesicles in microvascular permeability. In The Lung: Scientific Foundations. R. G. Crystal and J. B. West, editors. Lippincott-Raven Publishers, Philadelphia. 673-683.
16. 16. Verkman, A. S. 1998. Water transport and molecular water channels in lung. In Pulmonary Edema. M. A. Matthay and D. H. Ingbar, editors. Marcel Dekker, New York. 525-547.
17. 17. Albertine, K. H. 1998. Histopathology of pulmonary edema and the acute respiratory distress syndrome. In Pulmonary Edema. M. A. Matthay and D. H. Ingbar, editors. Marcel Dekker, New York. 37-83.
18. 18. Klagsbrun, M., and P. A. D'Amore. 1996. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev. 7:259-270.
19. 19. Ferrara, N., K. Houck, L. Jakeman, and D. W. Leung. 1992. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev. 13:18-32.
20. 20. Leung, D. W., G. Cachianes, W. J. Kuang, D. V. Goeddel, and N. Ferrara. 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309.
21. 21. Monacci, W. T., M. J. Merrill, and E. H. Oldfield. 1993. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am. J. Physiol. 624:C995-C1002.
22. 22. Tuder, R. M., B. E. Flook, and N. F. Voelkel. 1995. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J. Clin. Invest. 95:1798-1807.
23. 23. Senger, D. R., S. J. Galli, A. M. Dvorak, C. A. Perruzzi, V. S. Harvey, and H. F. Dvorak. 1983. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985.
24. 24. Thomas, K. A. 1996. Vascular endothelial growth factor, a potent and selective angiogenic agent. J. Biol. Chem. 271:603-606.
25. 25. Soker, S., S. Takashima, H. Q. Miao, G. Neufeld, and M. Klagsbrun. 1998. Neuropilin-1 is expressed by endothelial and tumor ceils as an isoform-specific receptor for vascular endothelial growth factor. Cell 92:735-745.
26. 26. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:27-31.
27. 27. Esser, S., K. Wolburg, H. Wolburg, G. Breier, T. Kurzchalia, and W. Risau. 1998. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J. Cell Biol. 140:947-959.
28. 28. Roberts, W. G., and G. E. Palade. 1995. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell Sci. 108:2369-2379.
29. 29. Roberts, W. G., and G. E. Palade. 1997. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res. 57:765-772.
30. 30. Mastrangeli, A., C. Danel, M. A. Rosenfeld, L. Stratford-Perricaudet, M. Perricaudel, A. Pavirani, J. P. Lecocq. and R. G. Crystal. 1993. Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J. Clin. Invest. 91:225-234.
31. 31. Rosenfeld, M. A., W. Siegfried, K. Yoshimura, K. Yoneyama, M. Fukayama, L. E. Stier, P. K. Paakko, P. Gilardi, L. D. Stratford-Perricaudet, M. Perricaudet, S. Jallat, A. Pavirani, J.-P. Lecocq, and R. G. Crystal. 1991. Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 252:431-134.
32. 32. Rosenfeld, M. A., K. Yoshimura, B. C. Trapnell, K. Yoneyama, E. R. Rosenthal, W. Dalemans, M. Fukayama, J. Bargon, L. E. Stier, L. Stratford-Perricaudet, M. Perricaudet, W. B. Guggino, A. Pavirani, J.-P. Lecocq, and R. G. Crystal. 1992. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68:143-155.
33. 165 expressed by a replication-deficient rccombinant adenovirus vector induces angiogenesis in vivo. Circ. Res. 77:1077-1086.
34. 34. Kong, H. L., D. Hecht, W. Song, I. Kovesdi, N. R. Hackett, A. Yayon, and R. G. Crystal. 1998. Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor. Hum. Gene Ther. 9:823-833.
35. 35. Hersh, J., R. G. Crystal, and B. Bewig. 1995. Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Ther. 2:124-131.
36. 36. Graham, F. L., and L. Prevec. 1991. Manipulation of adenovirus vectors. In Methods in Molecular Biology. E. J. Murray, editor. The Humana Press, Clifton, NY. 109-128.
37. 37. Turner, C. R., S. Zuczek, D. J. Knudsen, and E. B. Wheeldon. 1990. Microwave fixation of the lung. Stain Technol. 65:95-101.
38. 38. Green, T. P., D. E. Johnson, R. P. Marchessault, and C. W. Gatto. 1988. Transvascular flux and tissue accrual of Evans blue: effects of endotoxin and histamine. J. Lab. Clin. Med. 111:173-183.
39. 39. Saria, A., and J. M. Lundberg. 1983. Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues. J. Neurosci. Methods 8:41-49.
40. 40. Standiford, T. J., S. L. Kunkel, N. W. Lukacs, M. J. Greenberger, J. M. Danford, R. G. Kunkel, and R. M. Strieter. 1995. Macrophage inflammatory protein-1 alpha mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia. J. Immunol. 155:1515-1524.
41. 41. Jayr, C., C. Garat, M. Meignan, J. F. Pittet, M. Zelter, and M. A. Matthay. 1994. Alveolar liquid and protein clearance in anesthetized ventilated rats. J. Appl. Physiol. 76:2636-2642.
42. 42. Bai, C., N. Fukuda, T. Song, T. Ma, M. A. Matthay, and A. S. Verkman. 1999. Lung fluid transport in aquaporin-1 and aquaporin-4 knockout mice. J. Clin. Invest. 103:555-561.
43. 43. Kendall, R. L., and K. A. Thomas. 1993. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. USA 90:10705-10709.
44. 44. Pittet, J. F., R. C. Mackersie, T. R. Martin, and M. A. Matthay. 1997. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am. J. Respir. Crit. Care Med. 155:1187-1205.
45. 45. Lo, S. K., J. Everitt, J. Gu, and A. B. Malik. 1992. Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms. J. Clin. Invest. 89:981-988.
46. 46. Lo, S. K., B. Bevilacqua, and A. B. Malik. 1994. E-selectin ligands mediate tumor necrosis factor-induced neutrophil sequestration and pulmonary edema in guinea pig lungs. Circ. Res. 75:955-960.
47. 47. Cohen, T., D. Nahari, L. W. Cerem, G. Neufeld, and B. Z. Levi. 1996. Inter-leukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem. 271:736-741.
48. 48. Li, J., M. A. Perrella, J. C. Tsai, S. F. Yet, C. M. Hsieh, M. Yoshizumi, C. Patterson, W. O. Endege, F. Zhou, and M. E. Lee. 1995. Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells. J. Biol. Chem. 270:308-312.
49. 49. Ryuto, M., M. Ono, H. Izumi, S. Yoshida, H. A. Weich, K. Kohno, and M. Kuwano. 1996. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J. Biol. Chem. 271:28220-28228.
50. 50. Sirois, M. G., and E. R. Edelman. 1997. VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor. Am. J. Physiol. 272:H2746-H2756.
51. 51. Miotla, J. M., P. K. Jeffery, and P. G. Hellewell. 1998. Platelet-activating factor plays a pivotal role in the induction of experimental lung injury. Am. J. Respir. Cell Mol. Biol. 18:197-204.
52. 52. Lubman, R. L., K.-J. Kim, and E. D. Crandall. 1997. Alveolar epithelial barrier properties. In The Lung: Scientific Foundations. R. G. Crystal and J. B. West, editors. Lippincott-Raven Publishers, Philadelphia. 585-602.
53. 53. Gaudry, M., O. Bregerie, V. Andrieu, J. El Benna, M. A. Pocidalo, and J. Hakim. 1997. Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 90:4153-4161.
54. 54. Brigham, K. L., and B. Meyrick. 1986. Endoloxin and lung injury. Am. Rev. Respir. Dis. 133:913-927.
55. 55. Burger, P. C., D. B. Chandler, and G. K. Klintworth. 1983. Corneal neovascularization as studied by scanning electron microscopy of vascular casts. Lab. Invest. 48:169-180.
56. 56. Sholley, M. M., G. P. Ferguson, H. R. Seibel, J. L. Montour, and J. D. Wilson. 1984. Mechanisms of neovascularization. Vascular sprouting can occur without proliferation of endothelial cells. Lab. Invest. 51:624-634.
57. 57. Lazarous, D. F., M. Shou, M. Scheinowitz, E. Hodge, V. Thirumurti, A. N. Kitsiou, J. A. Stiber, A. D. Lobo, S. Hunsberger, E. Guetta, S. E. Epstein, and E. F. Unger. 1996. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 94:1074-1082.
58. 58. Kaner, R. J., S. Worgall, P. L. Leopold, E. Stolze, E. Milano, C. Hidaka, R. Ramalingam, N. H. Hackett, R. Singh, J. Bergelson, R. Finberg, E. Falck-Pedersen, and R. G. Crystal. 1998. Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/ adenovirus receptor. Am. J. Respir. Cell Mol. Biol. 20:361-370.
59. 59. Worgall, S., R. Singh, P. L. Leopold, R. J. Kaner, N. H. Hackett, N. Topf, M. A. S. Moore, and R. G. Crystal. 1998. Selective expansion of alveolar macrophages in vivo by ex vivo adenovirus-mediated transfer of the murine granulocyte-macrophage colony stimulating factor cDNA to and transplantation of modified macrophages to the lungs of syngeneic mice. Blood 93:655-666.
60. 60. Lemarchand, P., H. A. Jaffe, C. Danel, M. C. Cid, H. K. Kleinman, L. D. Stratford-Perricaudet, M. Perricaudet, A. Pavirani, J. P. Lecocq. and R. G. Crystal. 1992. Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells. Prof. Natl. Acad. Sci. USA 89:6482-6486.
61. 61. Zhou, M. Y., S. K. Lo, M. Bergenfeldt, C. Tiruppathi, A. Jaffe, N. Xu, and A. B. Malik. 1998. In vivo expression of neutrophil inhibitory factor via gene transfer prevents lipopolysaccharide-induced lung neutrophil infiltration and injury by a beta2 integrin-dependent mechanism. J. Clin. Invest. 101:2427-2437.